Literature DB >> 17509989

Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery.

Brad S Karon1, Gunjan Y Gandhi, Gregory A Nuttall, Sandra C Bryant, Hartzell V Schaff, M Molly McMahon, Paula J Santrach.   

Abstract

Intravenous insulin protocols are increasingly common in the intensive care unit to maintain normoglycemia. Little is known about the accuracy of point-of-care glucometers for measuring glucose in this patient population or the impact of sample source (capillary, arterial, or venous whole blood) on the accuracy of glucometer results. We compared capillary, arterial, and venous whole blood glucose values with laboratory plasma glucose values in 20 patients after cardiac surgery. All 4 samples (capillary, arterial, and venous whole blood and laboratory plasma glucose) were analyzed hourly for the first 5 hours during intravenous insulin therapy in the intensive care unit. There were no significant differences between median capillary whole blood (149 mg/dL [8.3 mmol/L]) and laboratory plasma (151 mg/dL [8.4 mmol/L]) glucose levels. The median arterial (161 mg/dL [8.9 mmol/L]) and venous (162 mg/dL [9.0 mmol/L]) whole blood glucose levels were significantly higher than the median laboratory plasma glucose level. Capillary whole blood glucose levels correlate most closely with laboratory plasma glucose levels in patients receiving intensive intravenous insulin therapy after cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509989     DOI: 10.1309/6RFQCKAAJGKWB8M4

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  31 in total

Review 1.  Blood glucose measurements in critically ill patients.

Authors:  Tom Van Herpe; Dieter Mesotten
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After Cardiovascular Surgery.

Authors:  Brad S Karon; Jeffrey W Meeusen; Sandra C Bryant
Journal:  J Diabetes Sci Technol       Date:  2015-08-25

Review 3.  Accuracy of point-of-care glucose measurements.

Authors:  Annette Rebel; Mark A Rice; Brenda G Fahy
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

4.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

5.  The new glucose standard POCT12-A3 misses the mark.

Authors:  Jan S Krouwer
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 6.  Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose.

Authors:  Kathie L Hermayer; Aundrea S Loftley; Sumana Reddy; Satya Nandana Narla; Nina A Epps; Yusheng Zhu
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

7.  Analytic evaluation of a new glucose meter system in 15 different critical care settings.

Authors:  John V Mitsios; Lori A Ashby; Doris M Haverstick; David E Bruns; Mitchell G Scott
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

8.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 9.  Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

10.  Accuracy of bedside glucometry in critically ill children with peripheral hypoperfusion.

Authors:  Anant Khositseth; Onsuthi Pharadornuwat; Rojjanee Lertbunrian; Nattachai Anantasit; Jarin Vaewpanich
Journal:  J Clin Monit Comput       Date:  2014-05-07       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.